FIVE MINUTE DAILY

The Pentagon loses another top general, Ukraine pushes the war deeper into Russian territory than ever before, and President Trump abruptly derails a bipartisan housing deal that had seemed all but finished.

Beyond the headlines, markets are reacting to shifting energy prices, scientists are uncovering tantalizing clues on Mars, and a potential breakthrough antibiotic offers fresh hope against drug-resistant superbugs. Today's edition follows the decisions—and discoveries—reshaping the weeks ahead.

Forward this to a friend who wants the world in five minutes.

58% of buyers now start their research in ChatGPT or Gemini, not Google. Most startups aren't showing up there yet.

The ones that are get cited by the AI tools their buyers, investors, and future hires already use. And they convert at 3×.

Download the free AEO Playbook for Startups from HubSpot and get the exact steps to start showing up. Five minutes to read.

Get the free playbook

Defense Secretary Pete Hegseth has pushed Gen. Christopher T. Donahue into resignation, ending the career of a four-star widely seen as the frontrunner for next Army chief of staff. Hegseth had viewed him with skepticism. That was enough.

It's the latest in a string of senior officer exits under the current Pentagon leadership. The shortlist for the Army's top job just got shorter, and the message about which command styles are out of favor inside the building couldn't be clearer.

Ukraine struck Russia's Orenburg gas plant — 1,200 kilometers inside Russian territory — marking the deepest confirmed Ukrainian strike of the entire war. Drone swarms also hit two Moscow satellite communications centers overnight, disrupting command networks in what Kyiv called a coordinated infrastructure campaign.

Sevastopol suffered a full power outage after separate Ukrainian drone strikes — the third time Crimea's grid has failed in as many weeks. Russian emergency services restored partial power within hours; military logistics across the peninsula remain disrupted as Ukraine continues to cut Russian supply lines.

Trump canceled the housing bill signing hours before it was scheduled, demanding Congress first pass his SAVE America Act before any deal reaches his desk. Markets had already priced in a housing boost; homebuilder stocks fell sharply as months of bipartisan negotiation appeared to collapse.

Senate Republicans left a tense Capitol meeting shaken, with several declining to comment and leadership offering no timeline for next steps. Trump told reporters the bill was "ready to go" but that he simply needed something bigger first.

A Trump-endorsed right-wing challenger narrowly won Colombia's presidential election by less than one percentage point — one of the closest results in the country's modern political history. Incumbent President Gustavo Petro has not conceded; his coalition is demanding a full recount.

The EU's top aviation regulator ordered immediate inspections of 16 Airbus A380s after cracks were found in the wings of the superjumbo, grounding five on the spot. The order hits airlines that still lean on the double-decker for their highest-volume long-haul routes.

Burnham edged closer to PM after no Labour challenger emerged before Tuesday's deadline — a coronation rather than a contest. Burnham has not yet named a cabinet, but BBC sources say Chancellor Rachel Reeves is expected to be replaced in his first reshuffle.

Postmaster General David Steiner confirmed a proposed rule under which USPS wouldn't deliver mail ballots in states that refuse to hand over voter data. If finalized, it puts the Postal Service in the middle of a brawl between the White House and state election officials.

New DNI Bill Pulte's staff cuts at intelligence agencies drew bipartisan condemnation Tuesday, with senior Republicans joining Democrats in calling the reductions a national security risk. Rep. Jim Himes, ranking member of the House Intelligence Committee, said eliminating experienced analysts was "exactly what our adversaries want."

The US Postal Service's reserves will last until 2031, not 2026 as previously projected — buying Congress time but not eliminating the underlying problem. Postmaster General David Steiner credited aggressive cost-cutting and rising package volume, while warning that long-term solvency still requires legislation.

PROTECT YOUR PRIVACY

Right now, data brokers you've never heard of are packaging up your name, home address, phone number, and income — and selling it to anyone willing to pay.

It's how you end up with spam calls, phishing emails, and your details floating around after every breach.

Incogni does the dirty work of getting it back.

It contacts data brokers on your behalf, demands your information be deleted, and keeps removing it automatically — from any site, any time, so it doesn't just creep back.

Right now you can get 55% off through the link below.

You can keep letting strangers profit off your private life — or take it back today.

Remove my data — 55% off

This is a paid advertisement. Five Minute Daily may earn a commission from purchases made through links in this email. Discount reflects 55% off and applies through the link above; offer subject to change by Incogni.

_{Please support our sponsors!}

Micron stock surged 16% on Wednesday after the memory chipmaker reported a roughly fourfold jump in revenue, driven by a severe industry-wide memory crunch. The pop extends a 700% rally over the past year.

Brent fell below $75 per barrel Tuesday — its lowest level since before the US-Iran conflict — as Hormuz ceasefire signals and Iran's sanctions waiver boosted supply expectations. Gasoline futures fell in tandem; analysts say a sustained break could flow through to pump prices within two weeks.

Qualcomm shares climbed 15% after the chipmaker nearly doubled its projection for non-handset revenue in 2029, signaling a serious push beyond smartphones into data center CPUs. Phones still make up two-thirds of product revenue, but Wall Street is now pricing in the pivot.

NASA's Perseverance rover detected complex carbon molecules in Martian rocks, the strongest hint yet of possible ancient biology on the Red Planet. Not proof of life — but the kind of chemistry scientists have spent decades hoping to see.

Japanese researchers used silver nanoparticles to cut and reassemble DNA more efficiently, improving recovery and joining rates over current methods. The technique could speed up gene engineering work that today is bottlenecked at the assembly stage.

Scientists captured the first-ever live footage of the goblin shark in its deep-sea habitat, with two sightings in the Central Pacific. The pink, protrusible-jawed creature had previously been known almost entirely from dead specimens hauled up in nets.

Austin Reaves agreed to a $185M extension — four years with the Lakers — the largest deal in NBA history for a player who entered the league undrafted in 2021. Reaves averaged 24 points per game last season and has become one of Los Angeles' two franchise cornerstones alongside LeBron James.

Christian Pulisic is healthy and starting for the United States against Turkey in Wednesday's must-win World Cup group stage match. Pulisic had missed training earlier in the week with a hamstring concern; coach Mauricio Pochettino confirmed him fit Tuesday afternoon.

Aliyah Boston leads WNBA All-Star voting, with Fever teammate Caitlin Clark running second as record fan engagement drives the league's most competitive ballot in years. Both are on track to start the All-Star Game; final rosters are decided next week.

The Paramount and Warner Bros. Discovery merger cleared antitrust review in more than a dozen countries, inching closer to a finalized deal. Combining the two would create one of the largest studio and streaming portfolios in the industry.

FX set a September 8 premiere for The Drop, a spinoff of the acclaimed drug-war drama Snowfall, which concluded in 2023. Original showrunners are involved; FX is betting the devoted Snowfall fan base will follow the franchise into a new chapter.

Live Nation's CEO spoke directly with Trump before the company's landmark antitrust settlement was finalized, drawing immediate scrutiny over the administration's regulatory dealings. Live Nation avoided a forced Ticketmaster breakup; the substance of the conversation has not been publicly disclosed.

SAVE ON COVERAGE

Simply taking the time to shop for better options could save you up to $600 per year when you switch.

All you need to do is enter your zip code and basic vehicle information to compare top insurance options and see if you could save.

Compare car insurance options now.

_{Please support our sponsors!}

What it is: Scientists discovered a new antibiotic cocktail derived from soil bacteria capable of eliminating drug-resistant pathogens — including MRSA and carbapenem-resistant Enterobacteriaceae — that modern medicine cannot currently kill. Both are on the WHO's list of critical priority pathogens, collectively responsible for hundreds of thousands of hospital deaths every year, with treatment options running out as resistance spreads globally.

The detail: Compounds in this cocktail attack bacteria through a pathway entirely distinct from every antibiotic class in clinical use today, targeting structural vulnerabilities that have not been previously exploited by any approved drug. Lab results show near-complete pathogen elimination with no observed rapid resistance development — suggesting these bacteria have no ready evolutionary counter to this particular mechanism.

Why it matters: Drug-resistant infections already kill an estimated 1.27 million people per year globally and are projected to surpass cancer as a leading cause of death by 2050, according to a landmark 2022 Lancet study. A new antibiotic class hasn't been discovered in roughly four decades — finding one would reset medicine's clock in the arms race against bacterial evolution.

What to watch: These compounds are still preclinical, with human trials likely years away, and the pharmaceutical industry has a mixed track record bringing soil-derived antibiotics through development when commercial incentives don't justify the cost. Congress passed antibiotic development incentives in 2024; watch for NIH grants and pharma partnerships in the coming months as signals that this discovery won't stall in the pipeline.

Thanks for reading Five Minute Daily. Share this with someone who wants a clear morning brief, and subscribe to get the next edition.

—The Five Minute Daily Team